Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

3 Reasons Why Canadian Companies Continue To Impress Investors



This article is published in collaboration with Scutify, where you can find real-time markets and stock commentary from Robert Marcin, Cody Willard and others. Download the Scutify iOS App, the Scutify Android App or visit

The first half of 2017 is over and marijuana investors are ready to capitalize on emerging market trends.

We expect to see a lot of developments during the second half of the year and want to highlight three recent developments that cannabis investors should be aware of.

Aurora Cannabis Continues to Execute

Aurora Cannabis (ACB.V) (ACBFF) received a positive response from the market after it was reported that the company will join Canopy Growth (WEED.TO) (TWMJF), Aphria (APH.TO) (APHQF), CanniMed (CMED.TO) (CMMDF), and MedReleaf (LEAF.TO) on the TSX Exchange.

We continue to remain favorable on Aurora Cannabis due its management team which continues to execute and create value for shareholders and its balance sheet which is flush with cash and able to support its growth initiatives.

Golden Leaf Closes Acquisition and Trades Higher

Golden Leaf Holdings Ltd (GLH.CN) (GLDFF) traded higher after the company entered a definitive agreement regarding its previously announced acquisition of Chalice LLC, a vertically integrated Oregon cannabis company. Chalice Farms operates a chain of four branded retail dispensary stores in Oregon and named "Cannabis Store of the Year" at the 2017 Dope Magazine Industry Awards in Oregon.

Chalice is involved with the cultivation, extraction, refinement, marketing and sales of cannabis flower, edibles and oils. Chalice Farms has developed a branded portfolio of cannabis products that have significant market shares and brand equity in Oregon.

The closing of this deal is expected to drive financial and shareholder value. Management said the integration of the two companies allows for increased revenues with reduced costs and will result in significant synergies.

We continue to remain favorable on the opportunity that Golden Leaf has to create value for shareholders through its recent acquisitions. The management team continues to execute on its strategy and we continue view Golden Leaf as a company to watch.

CannaRoyalty Continues to Move Higher

CannaRoyalty Corp. (CRZ.CN) (CNNRF) edged higher after the company said that its newly formed CR Advisory Services division secured its first engagement with one of its investee companies Alternative Medical Enterprises, LLC.

Terms of the CR Advisory engagement with AltMed include an upfront fee of $150,000, plus a success fee on corporate transactions undertaken by AltMed during the consulting services agreement or within six months after termination of the agreement. CR Advisory was established to provide consulting and advisory services to the global cannabis industry and will provide a full suite of advisory services within the areas of corporate finance, capital markets, compliance and regulation, accounting, operations, as well as retail and sales strategy.

While we are favorable on the company's opportunity, the shares are up almost 40% in the last month and we continue to monitor company developments. CannRoyalty has found some resistance in its current range and the shares are right below overbought territory. We will monitor the shares to see if they can break out of its current range.

Stay up to date with Cannabis Wheaton by Joining Technical420...

Important Investor Disclosures

This report was authored by and is property of Technical420. All information and data relied upon in drafting this report is publicly available. The author believes and considers its sources to be reliable, but does not guarantee the accuracy or completeness of any information contained in this report. Any and all information, data, analyses and opinions are provided for informational purposes only and is not intended, in any manner, as investment advice. Any projections or other information generated by Technical420 regarding the likelihood of various investment outcomes are hypothetical in nature, do not reflect actual investment results, and are not guarantees of future results. None of the material contained in this report is intended as a solution or offer to sell or purchase a specific stock or any other investment. This report is not directed to, or intended for distribution or use by, any person or entity that is a citizen, resident or located in any municipality, state, country or other jurisdiction where the distribution, publication, availability, or use of this report is contrary to any governing law or regulation. The securities discussed in this report may not be eligible for purchase and/or sale in certain jurisdictions or by particular individuals. It is important that you check any and all governing laws and/or regulations that may be applicable in your jurisdiction. Investing in securities of issuers organized outside of the United States, including ADRs, entail certain risks. The securities of non-United States issuers may not be registered with, nor be subject to the reporting requirements of the United States Securities and Exchange Commission. Please contact a Financial Advisor for professional advice regarding any and all securities investments. This report is intended for informational purposes only

This article was written by Mark Maulden for on .

This article published in collaboration with Scutify, the best app for traders and investors. Download the Scutify iOS App, the Scutify Android App or visit

< Previous
  • 1
Next >
Featured Videos